BIT 0.00% 1.9¢ biotron limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-27

  1. 4,215 Posts.
    lightbulb Created with Sketch. 664
    MM has already stated NO MORE Trials for Biotron for our lead compound at the completion of these trials…… There is no clinical phase 2 C trials lol
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.